Background
==========

Hepatotoxicity is the most widespread pathology worldwide, representing up to 83% of all cases. Hepatitis, viral infections, food additives, alcohol, toxic industrial chemicals, and air and water pollutants are the major risk factors of liver toxicity. There is increasing evidence that free radicals and reactive oxygen species play a crucial role in various steps that initiate and regulate the progression of liver diseases independently of the original agent \[[@B1]\]. Carbon tetrachloride (CCl~4~) is a potent environmental hepatotoxin \[[@B2]\] that, in addition to hepatic problems, causes dysfunction of the kidneys, lungs, testis, brain, and blood by generating free radicals \[[@B3],[@B4]\].

CCl~4~ requires bioactivation in phase I of the cytochrome P450 system to form the reactive metabolic trichloromethyl radical (·CCl~3~) and trichloromethyl peroxy radical (·OOCCl~3~). These free radicals can bind with polyunsaturated fatty acids to produce alkoxy (R·) and peroxy radicals (ROO·) that, in turn, generate lipid peroxides that are highly reactive, change enzyme activity, and finally induce injury or necrosis with corresponding health problems \[[@B5],[@B6]\].

CCl~4~ is known to decrease glutathione (GSH) of phase II enzymes and reduce antioxidant enzymes and substrates to induce oxidative stress, which is an important factor in acute and chronic injuries in various tissues \[[@B7],[@B8]\]. Free radicals of CCl~4~ reduce the GSH contents and activities of antioxidant enzymes, leading to hepatic injury \[[@B9]\]. The depletions of these antioxidant enzymes occur secondary to the controlling action against peroxy radicals produced by CCl~4~. Reactive oxygen species cause oxidative DNA damage in the form of DNA adducts, genetic mutation, strand breakage, and chromosomal alterations \[[@B10]\]. Some recent investigations revealed that free radicals increased the number of argyrophilic nucleolar organizer regions (AgNORs) and activity of telomerase in kidney tissues \[[@B11]\], caused depletion of cytochrome P450 2E1, and increased the 8-hydroxyl-2 deoxyguanosine concentration \[[@B12]\]. DNA fragmentation causes p53 gene expression, blocks the cell cycle, and gives additional time to repair DNA. However, severe DNA damage triggers apoptosis \[[@B13]\].

*Sonchus asper* (SAME), locally called Mahtari, is a common herb that grows wildly and abundantly in open fields. Chemical studies of SAME indicated a high content of vitamin C (ascorbic acid) \[[@B14]\], carotenoids, and type ω-3 fatty acids \[[@B15],[@B16]\]. Phenolic compounds, which are secondary metabolites in plants, are one of the most widely occurring groups of phytochemicals that exhibit a wide range of physiological properties, such as antioxidant, anti-allergenic, anti-microbial, anti-artherogenic, anti-thrombotic, anti-inflammatory, vasodilatory, and cardioprotective effects \[[@B17],[@B18]\]. Chemical characterization of SAME has shown the presence of ionone derivatives of glycosides and sesquiterpene lactone glycosides \[[@B19]\]. These bioactive compounds have been shown to possess strong antioxidant and anti-inflammatory properties \[[@B20]\]. SAME has diuretic, refrigerant, sedative, and antiseptic properties that are used in the treatment of cough, bronchitis, and asthma \[[@B21]\] as well as kidney inflammation \[[@B22]\], and its decoction is used in the treatment of impotence (erectile dysfunction) \[[@B23]\]. With increasing recognition of herbal medicine and phytotherapy as alternative forms of health care, the objectives of this study were to evaluate the antioxidant and hepatoprotective properties of SAME against CCl~4~-induced hepatic injuries in Sprague--Dawley male rats.

Methods
=======

Chemicals
---------

Reduced glutathione (GSH), oxidized glutathione (GSSG), glutathione reductase, gamma-glutamyl p-nitroanilide, glycylglycine, bovine serum albumin (BSA), 1,2-dithio-bis nitro benzoic acid (DTNB), 1-chloro-2,4-dinitrobenzene (CDNB), reduced nicotinamide adenine dinucleotide phosphate (NADPH), CCl~4~, flavine adenine dinucleotide (FAD), glucose-6-phosphate, Tween-20, 2,6-dichlorophenolindophenol, thiobarbituric acid (TBA), picric acid, sodium tungstate, sodium hydroxide, trichloroacetic acid (TCA) and perchloric acid (PCA) were purchased from Sigma Chemicals Co. USA.

Plant collection
----------------

Plants of *Sonchus asper* at maturity were collected from Wah Cantt, District Rawalpindi (Pakistan) during June, 2010. Plants were identified by Prof. Dr. Mir Ajab Khan (Dean Faculty of Biological Sciences, Quaid-i-Azam University Islamabad, Pakistan) and a specimen was submitted vide \#147 at Herbarium of Pakistan (Quaid-i-Azam University Islamabad, Pakistan). Whole plant (leaves, stem, flowers, roots and seeds) were shades dried at room temperature for two weeks, chopped, ground mechanically of 1 mm mesh size.

Preparation of plant extracts
-----------------------------

Five kg powder of *Sonchus asper* was socked in 10 liters of methanol with shaking a number of times. After a week of socking the extract was filtered through Whatmann filter paper \# 45, and the filtrate was evaporated through rotary vacuum evaporator to get 407 g of methanol crude extract (SAME), stored at 4°C until further use.

Animals
-------

Six week old, 36 Sprague Dawley male rats (190--200 g) were provided by National Institute of Health Islamabad and were kept in ordinary cages at room temperature of 25 ± 3°C with a 12 h dark/light cycle. They were allowed to standard laboratory feed and water. The study protocol was approved by Ethical Committee of Quaid-i-Azam University Islamabad for laboratory animal feed and care.

Experimental design
-------------------

To study the antioxidant effects of SAME, rats were equally divided into 6 groups (6 rats). Group 1 received only vehicles olive oil; (1 ml/kg bw) and DMSO (1 ml/kg bw) and have free access to food materials. Animals of group II, III and IV received CCl~4~ 3 ml/kg (30% in olive oil; v/v) intraperitoneally twice a week for four weeks. Group II was treated with CCl~4~ only while group III (100 mg/kg bw) and IV received (200 mg/kg bw) SAME (intragastric, in DMSO) after 48 h of CCl~4~. Rats of group V were given silymarin (intragastric, in DMSO) at a dose of 100 mg/kg bw, after 48 h of CCl~4~ treatment. Animals of a group VI were given SAME (200 mg/kg bw) intragastrically. Experimental period was of four weeks. After 24 h of the last treatment, all the animals were weighted, sacrificed; collected their blood, weighted and perfuse a liver in ice-cold saline solution. Half of liver tissues was treated with liquid nitrogen for further enzymatic and DNA damage analysis while the other portion was processed for histology.

Assessment of serum markers
---------------------------

Serum analysis of various liver marker enzymes such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), lactate dehydrogenase (LDH) and biochemical markers; level of total cholesterol (TC), high-density lipoproteins (HDL), low-density lipoproteins (LDL) and triglycerides (TG) were estimated by using standard AMP diagnostic kits (Stattogger Strasse 31b 8045 Graz, Austria).

Assessment of antioxidant status
--------------------------------

70 mg of liver tissue was homogenized in 10 volumes of 100 mmol KH~2~PO~4~ buffer containing 1 mmol EDTA (pH 7.4) and centrifuged at 12,000 × g for 30 min at 4°C. The supernatant was collected and used for determination of antioxidant status as described below using concentration of protein estimated following the method of Lowry et al. \[[@B24]\]. Antioxidant status, including activity of catalase \[[@B25]\], superoxide dismutase \[[@B26]\], glutathione-S-transferase assay \[[@B27]\], glutathione reductase \[[@B28]\], glutathione peroxidase \[[@B29]\], reduced glutathione assay \[[@B30]\] and lipid peroxidation assay \[[@B31]\] were performed on various hepatic samples.

DNA fragmentation% assay
------------------------

DNA fragmentation assay was conducted using the procedure of Wu et al. \[[@B32]\] with some modifications. The liver tissue (50 mg) was homogenized in 10 volumes of a TE solution pH 8.0 (5 mmol Tris--HCl, 20 mmol EDTA) and 0.2% triton X-100. 1.0 ml aliquot of each sample was centrifuged at 27,000 × g for 20 min to separate the intact chromatin (pellet, B) from the fragmented DNA (supernatant, T). The pellet and supernatant fractions were assayed for DNA content using a freshly prepared DPA (Diphenylamine) solution for reaction. Optical density was read at 620 nm with (SmartSpecTM Plus Spectrophotometer catalog \# 170--2525) spectrophotometer. The results were expressed as an amount of % fragmented DNA by the following formula;$\%\text{Fragmented\ DNA} = \text{T} \times 100/\left( \text{T} + \text{B} \right)$

AgNORs count
------------

Silver staining technique was used according to the Trere et al. \[[@B33]\]. The AgNORs technique was performed on dried slides as follows; unstained fixed slides were dewaxed by dipping for 3 minutes in xylene. After complete removal of wax, the slides were hydrated in decreasing ethanol concentration (90, 70 and 50%) and washed in distilled water for 10 min and dried in an oven. After drying slides were treated with one drop of colloidal solution (2% gelatin and 1% formic acid) and two drops of 50% AgNO~3~ solution on the slide and incubated at 35°C for about 8--12 min. The progressive staining was followed under a microscope to get golden colored nuclei and brown/black NORs. Then, the slide was washed in distilled water, treated for 1 min with 1% sodium thiosulphate at room temperature to stop the reaction, and washed in tap water. The cells were examined under a light microscope at 100 × magnifications and number of AgNORs was counted per cell.

Histopathological studies
-------------------------

For microscopic evaluation, liver were fixed in a fixative (absolute ethanol 60%, formaldehyde 30%, and glacial acetic acid 10%) and embedded in paraffin, sectioned at 4 μm and subsequently stained with hematoxylin/eosin. Sections were studied under a light microscope (DIALUX 20 EB) at 40 and 100 magnifications. Slides of all the treated groups were studied and photographed.

Statistical analysis
--------------------

Data were expressed as mean and standard error (SE) and ANOVA test were used to analyze the difference among various treatments, with least significance difference (LSD) at 0.05 and 0.01 as a level of significance. SPSS ver. 14.0 (Chicago, IL, USA) and Microsoft Excel 2007 (Roselle, IL, USA) were used for the statistical and graphical evaluations.

Results
=======

Effect of SAME on alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, and lactate dehydrogenase
-----------------------------------------------------------------------------------------------------------------------

The levels of certain serum marker enzymes, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH), are highly susceptible to hepatotoxins. They serve as markers of liver damage and oxidative stress, which promote the release of aminotransferases from hepatocytes into the bloodstream. The protective effects of SAME and silymarin on the activity of liver serum marker enzymes are shown in Table [1](#T1){ref-type="table"}. Administration of CCl~4~ to rats significantly (P \< 0.01) increased the activity of liver serum marker enzymes compared with controls. The levels of ALT, AST, ALP, and LDH were significantly (P \< 0.01) and dose-dependently restored by treatment with SAME and silymarin compared with the CCl~4~ group. However, non-significant variation was observed by SAME treatment alone compared with the control group.

###### 

Effect of SAME on liver function test in rat

  **Treatment**                  **ALT**           **AST**              **ALP**              **LDH (nmol/min/**
  ------------------------------ ----------------- -------------------- -------------------- --------------------
  Control                        52. ± 2.12++      76 ± 2.74++          198 ± 3.93++         48.3 ± 2.38++
  3 ml/kg CCl~4~                 111 ± 3.42\*\*    234.0 ± 4.27\*\*     470.3 ± 6.49\*\*     77.6 ± 2.46\*\*
  100 mg/kg SAME + CCl~4~        91 ± 3.23\*\*++   136 ± 4.91\*\*++     347.7 ± 10.7\*\*++   66 ± 3.76\*\*+
  200 mg/kg SAME + CCl~4~        56 ± 1.35++       97.5 ± 2.90\*\*++    217.8 ± 3.91\*++     53 ± 2.61++
  100 mg/kg Silymarin + CCl~4~   58 ± 2.68++       102.3 ± 4.99\*\*++   227.5 ± 3.89\*\*++   50 ± 4.08++
  200 mg/kg SAME alone           50 ± 2.14++       75.5 ± 3.26++        195.3 ± 4.11++       46 ± 2.38++

Mean ± SE (n = 6 number).

\*\* Significance from the control group at *P \<* 0.01 probability level.

++ Significance from the CCl~4~ group at *P \<* 0.01 probability level.

Effect of SAME on triglycerides, total cholesterol, high-density lipoprotein, and low-density lipoprotein
---------------------------------------------------------------------------------------------------------

The effect of SAME on the cholesterol profile is shown in Table [2](#T2){ref-type="table"}. Administration of CCl~4~ significantly (P \< 0.01) increased the concentration of triglycerides, total cholesterol, and low-density lipoprotein, but decreased the high-density lipoprotein level compared with the control group. The CCl~4~-induced alteration of the cholesterol profile was significantly (P \< 0.01) restored with SAME treatment at both doses (100 mg/kg and 200 mg/kg) compared with the control group. Silymarin resulted in a degree of recovery of the cholesterol profile comparative with that achieved with the high dose of SAME.

###### 

Effect SAME on serum level of biochemical markers in rat

  **Treatment**                  **Triglycerides (mg/dl)**   **Total cholesterol (mg/dl)**   **HDL (mg/dl)**     **LDL (mg/dl)**
  ------------------------------ --------------------------- ------------------------------- ------------------- ------------------
  Control                        7.8 ± 0.45++                6.1 ± 0.25++                    3.6 ± 0.21++        2.48 ± 0.32++
  3 ml/kg CCl~4~                 11.3 ± 0.58\*\*             11.2 ± 0.23\*\*                 2.8 ± 0.18\*\*      8.4 ± 0.17\*\*
  100 mg/kg SAME + CCl~4~        9.2 ± 0.41\*\*++            7.7 ± 0.21\*\*++                3.08 ± 0.09\*\*++   4.2 ± 0.21\*\*++
  200 mg/kg SAME + CCl~4~        8.3 ± 0.18++                6.4 ± 0.27++                    3.5 ± 0.20++        2..53 ± 0.35++
  100 mg/kg Silymarin + CCl~4~   7.2 ± 0.44++                5.7 ± 0.19++                    3.7 ± 0.21++        2.21 ± 0.31++
  200 mg/kg SAME alone           7.5 ± 0.44++                5.8 ± 0.44++                    3.75 ± 0.21++       2.36 ± 0.12++

Mean ± SE (n = 6 number).

\*\* Significance from the control group at *P \<* 0.01 probability level.

++ Significance from the CCl~4~ group at *P \<* 0.01 probability level.

Effect of SAME on antioxidant and lipid peroxidation enzymes in liver
---------------------------------------------------------------------

The toxicity of CCl~4~ significantly decreased the liver catalase, superoxide dismutase, GSH S-transferase, GSH peroxidase (GSH-Px), and GSH reductase levels of the control group (Table [3](#T3){ref-type="table"}). Addition of SAME at doses of 100 and 200 mg/kg and silymarin at 100 mg/kg reversed the decreased hepatic catalase and superoxide dismutase levels. In particular, the high dose of SAME (200 mg/kg) almost completely restored the catalase and superoxide dismutase activities to the control levels. The hepatic levels of GSH S-transferase, GSH-Px, and GSH reductase were partially reversed by SAME at 200 mg/kg.

###### 

Effect of SAME on antioxidant defense system in rat liver

  **Treatment**                  **CAT**          **SOD**           **GST**         **GR**             **GSH-Px**
  ------------------------------ ---------------- ----------------- --------------- ------------------ --------------
  Control                        4.8 ± 0.10++     22.7 ± 1.18++     192 ± 2.49++    127.3 ± 10.5++     84.2 ± 5.9++
  3 ml/kg CCl~4~                 2.9 ± 0.06\*\*   11.9 ± 0.38\*\*   104 ± 2.4\*\*   62.33 ± 9.28\*\*   46 ± 3.6\*\*
  100 mg/kg SAME + CCl~4~        4.04 ± 0.09++    16.2 ± 0.38\*++   142 ± 2.6\*++   90.2 ± 11.3\*++    61 ± 6.6\*++
  200 mg/kg SAME + CCl~4~        4.8 ± 0.125++    20.4 ± 0.37++     190 ± 2.9++     112.3 ± 6.5++      75 ± 4.2++
  100 mg/kg Silymarin + CCl~4~   4.9 ± 0.116++    22.9 ± 0.57++     201 ± 2.5++     134.3 ± 5.7++      84 ± 4.0++
  200 mg/kg SAME alone           4.96 ± 0.05++    24.7 ± 0.38++     199 ± 2.19++    132.3 ± 6.96++     87 ± 3.5++

Mean ± SE (n = 6 number).

\*, \*\* Significance from the control group at *P \<* 0.05 and *P \<* 0.01 probability level.

++ Significance from the CCl~4~ group at *P \<* 0.01 probability level.

Effect of SAME on GSH and thiobarbituric acid-reactive substances in liver
--------------------------------------------------------------------------

The hepatic level of GSH was decreased while the thiobarbituric acid-reactive substances (TBARS) were increased in the CCl~4~-treated animals compared with the controls (Table [4](#T4){ref-type="table"}). The CCl~4~-induced changes in these parameters were dose-dependently diminished by oral addition of various doses of SAME and silymarin. No significant changes in GSH or TBARS were found with SAME alone compared with control rats.

###### 

Effect SAME on TBARS and GSH contents in rat liver

  **Treatment**                  **GSH (μmol/g tissue)**   **TBARS (nmol /min /mg protein)**
  ------------------------------ ------------------------- -----------------------------------
  Control                        1.23 ± 0.02++             28.33 ± 1.12++
  3 ml/kg CCl~4~                 0.60 ± .012\*\*           52.17 ± 2.61\*\*
  100 mg/kg SAME + CCl~4~        1.09 ± 0.02\*\*++         43.0 ± 2.76\*\*++
  200 mg/kg SAME + CCl~4~        1.81 ± 0.50++             30.0 ± 1.77++
  100 mg/kg Silymarin + CCl~4~   1.27 ± 0.013++            27.17 ± 1.22++
  200 mg/kg SAME alone           1.25 ± 0.018++            27.50 ± 1.82++

Mean ± SE (n = 6 number).

\*\* Significance from the control group at *P \<* 0.01 probability level.

++ Significance from the CCl~4~ group at *P \<* 0.01 probability level.

Effect of SAME on body weight, absolute liver weight, relative liver weight, % DNA fragmentation, and AgNORs in rat liver
-------------------------------------------------------------------------------------------------------------------------

The NORs stained by silver ion and the AgNOR-associated proteins, called AgNOR proteins, play a significant role in differentiation of tumor cells from normal cells, as shown along with increases in liver weight, relative liver weight, % DNA fragmentation, and % increases in body weight (Table [5](#T5){ref-type="table"}). Administration of CCl~4~ significantly (P \< 0.01) amplified the number of NORs per cell, increased the liver weight, increased the relative liver weight, increased the % DNA fragmentation, and decreased the % increase in body weight compared with untreated rats. However, 50 mg/kg of silymarin and various doses of SAME augmented the CCl~4~-induced intoxication and significantly (P \< 0.01) recovered the NORs per cell, body weight, liver weight, and relative liver weight. The % DNA fragmentation was markedly (P \< 0.01) decreased.

###### 

Effect of SAME on absolute liver weight, relative liver weight, and % DNA fragmentation and AgNORs in rat liver

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Treatment**                  **% increase in**\   **Absolute liver weight (g)**   **Relative liver weight (% to body weight)**   **AgNORs (NORs/cell)**   **%DNA fragmentation**
                                 **body weight**                                                                                                              
  ------------------------------ -------------------- ------------------------------- ---------------------------------------------- ------------------------ ------------------------
  Control                        35.00 ± 0.87++       7.0 ± 0.23++                    0.07 ± 0.002++                                 2.0 ± 0.33++             5.33 ± 2.46++

  3 ml/kg CCl~4~                 24.52 ± 0.92\*\*     8.6 ± .89\*\*                   0.86 ± .0016\*\*                               6.4 ± .29\*\*            22.50 ± 3.68\*\*

  100 mg/kg SAME + CCl~4~        30.08 ± 0.81\*\*++   7.4 ± 0.10\*++                  0.074 ± 0.001\*++                              3.5 ± 0.18\*\*++         6.67 ± 2.08++

  200 mg/kg SAME + CCl~4~        35.64 ± 0.73++       7.04 ± 0.23++                   0.070 ± 0.0023++                               2.14 ± 0.23++            5.67 ± 3.12++

  100 mg/kg Silymarin + CCl~4~   36.82 ± 0.69++       6.83 ± 0.07++                   0.068 ± 0.007++                                1.9 ± 0.17\*\*++         4.67 ± 2.23++

  200 mg/kg SAME alone           35.72 ± 0.70++       6.8 ± 0.12++                    0.068 ± 0.011++                                1.96 ± 0.12++            5.50 ± 3.2++
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Mean ± SE (n = 6 number).

\*, \*\* Significance from the control group at *P \<* 0.05 and *P \<* 0.01 probability level.

++ Significance from the CCl~4~ group at *P \<* 0.01 probability level.

Effect of SAME on liver histology
---------------------------------

Histopathological investigation results showed significant correlations with the biochemical study results. The graded observations of hematoxylin and eosin-stained sections are shown in Table [6](#T6){ref-type="table"} and Figure [1](#F1){ref-type="fig"}. Administration of CCl~4~ caused marked increases in fatty changes and cellular hypertrophy; cellular aggregation caused benign tumor formation, and inflammatory cell infiltration, ballooning, and congestion of blood vessels were observed compared with controls. Administration of SAME attenuated the hepatic injuries with little or no fatty changes; dilation of blood vessels and uniform hepatocyte morphology nearly identical to that of the control group was found. Similar observations were recorded after silymarin treatment. These results suggest a positive correlation of SAME and silymarin with the activities of serum aminotransferases and hepatic lipid peroxidation and hepatic antioxidant enzymes.

###### 

Effects of SAME on histology of liver

  **Treatment**                  **Fatty changes**   **Cellular aggregation hypertrophy**   **Blood vessel congestion**   **Inflammatory cells infiltrations**
  ------------------------------ ------------------- -------------------------------------- ----------------------------- --------------------------------------
  Control                        \-                  \-                                     \-                            \-
  3 ml/kg CCl~4~                 +++                 ++                                     ++                            +++
  100 mg/kg SAME + CCl~4~        \-                  −/+                                    \-                            −/+
  200 mg/kg SAME + CCl~4~        \-                  \-                                     \-                            \-
  100 mg/kg Silymarin + CCl~4~   \-                  \-                                     \-                            \-
  200 mg/kg SAME alone           \-                  \-                                     \-                            \-

**-,** normal; +/−, mild; ++, medium; +++, severe disruption.

![**(a) Hemotoxylin and Eosin-stained liver section of control rat (b) Liver section of CCl**~**4**~**treated rats showing marked fatty changes, cellular hypertrophy, degeneration of the lobular architecture and blood vessel congestion with disturbed epithelium (c) Liver section of CCl**~**4**~ **+ SAME showing less injuries (d) Liver section of CCl**~**4**~ **+ Silymarin showing less injuries.**.](1472-6882-12-90-1){#F1}

Discussion
==========

A number of drugs, toxic industrial chemicals, and viral infections have been reported to cause severe hepatic injuries, which are sometimes difficult to manage by medical therapies. It is important to evaluate plant extracts that can be used for improved treatment of hepatic failure caused by severe oxidative stress and necrosis \[[@B34]\]. Estimation of serum enzymes is a useful quantitative marker of the extent and type of hepatocellular damage. Increases in serum AST, ALT, ALP, and LDH levels have been attributed to damaged structural integrity of the liver, because these are cytoplasmic in location and are released into the circulation after autolytic breakdown or cellular necrosis \[[@B35]\]. Therefore, marked release of AST, ALT, ALP, and LDH into the circulation indicates severe damage to hepatic tissue membranes during CCl~4~ intoxication \[[@B36]\]. The reversal of increased serum enzymes in CCl~4~-induced liver damage by SAME may occur secondary to prevention of leakage of intracellular enzymes by the membrane stabilization and antioxidant activity of SAME; this was supported by the histological results in the present study. Thus, the anti-lipid peroxidation and/or adaptive nature of the systems brought about by SAME acted against the damaging effects of free radicals produced by CCl~4~. Similar hepatoprotective effects have been described for *S. arvensis*\[[@B37]\]. High levels of serum cholesterol, low-density lipoprotein, and triglycerides and lower concentrations of high-density lipoprotein were induced with CCl~4~ in rats, consistent with results of other studies \[[@B36],[@B38],[@B39]\].

Catalase, superoxide dismutase, and GSH-Px constitute a "mutually supportive team" of antioxidant defenses and play a key role in detoxification of free radicals \[[@B40],[@B41]\]. Administration of CCl~4~ into rat livers increased lipid peroxidation, resulting in accumulation of superoxide radicals and consequently decreased their activities in the liver \[[@B42]\]. Our data revealed that CCl~4~ treatment significantly decreased the activities of catalase, superoxide dismutase, GSH-Px, and GSH reductase in liver tissues. Co-administration of SAME markedly decreased the toxicity of CCl~4~ and enzymatic activities. Ameliorating effects of different plant metabolites on these enzymes against the toxicity of CCl~4~ have also been documented \[[@B42]\]. TBARS is a major reactive aldehyde resulting from the peroxidation of polyunsaturated fatty acids. It is a useful indicator of tissue damage, including a series of chain reactions \[[@B43]\]. High hepatic levels of TBARS and nitrite with CCl~4~ treatment indicate extensive oxidative damage to liver tissues. Restoration of nitrite and TBARS with SAME may suggest a role of SAME in controlling various pathological conditions, including oxidative stress \[[@B20]\]. Histopathologic results in the present study revealed that CCl~4~ induces extensive fatty change, blood vessel congestion, cellular hypertrophy, necrotic foci, destruction of the lobular architecture, fibrosis, and nuclear degeneration in some areas, all of which were markedly diminished by induction of SAME*.* These data are in good agreement with the results of the serum aminotransferase activities and hepatic lipid peroxidation levels. Similar protection was evident with respect to necrosis, which is a more severe form of injury, in that it was minimized by treatment with SAME. Other studies on the protective effect of *Carissa opaca* extract against CCl~4~-induced hepatotoxicity in rats have revealed similar findings that are in agreement with the present findings \[[@B44]\].

Conclusions
===========

This study evaluated the pharmacological use of SAME against CCl~4~ induced liver injuries. Low lipid peroxidation and increased activities of various antioxidant enzymes indicate that SAME is able to protect various pathological conditions, including oxidative stress. It is suggested, to isolate the antioxidants from SAME that could be utilized as therapeutics against the oxidative diseases.
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